LOGIN  |  REGISTER
Astria Therapeutics

Hinge Health (NYSE: HNGE) Stock Quote

Last Trade: US$ 0
Volume: 0
5-Day Change: 0%
YTD Change: 0%
Market Cap: -

Latest News From Hinge Health

SAN FRANCISCO / Nov 24, 2025 / Business Wire / Hinge Health, Inc. (NYSE: HNGE) today announced a new study showing that participants in its chronic back pain program had substantially fewer imaging visits, such as X-rays and MRIs, compared to a similar group of individuals who sought traditional PT care. The peer-reviewed study, published in The Journal of Health Economics and Outcomes Research found that of the 4,330... Read More
SAN FRANCISCO / Nov 12, 2025 / Business Wire / Hinge Health, Inc. (NYSE: HNGE) today announced that its board of directors has authorized a $250 million share repurchase program. “During the first three quarters of 2025, we generated $108 million in cash from operations and $118 million in free cash flow 1 , reflecting the strength and scalability of our business model,” said James Budge, CFO, Hinge Health. “We maintain a... Read More
SAN FRANCISCO / Nov 04, 2025 / Business Wire / Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2025. “With healthcare costs rising dramatically, our mission to automate care delivery has never been more urgent,” said Daniel Perez, Co-Founder and CEO, Hinge Health. “This quarter we surpassed 1.5 million lifetime members, delivered year-over-year revenue growth of... Read More
SAN FRANCISCO / Oct 21, 2025 / Business Wire / Hinge Health, Inc. (NYSE:HNGE) today announced two AI-powered care tools: Movement Analysis uses computer vision to set a new standard for tracking musculoskeletal (MSK) outcomes, and Robin is an AI Care Assistant that provides instant support for members. Hinge Health also published its AI care principles, which guide the development of AI across its platform. “Our thoughtful... Read More
SAN FRANCISCO / Oct 01, 2025 / Business Wire / Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2025, after the U.S. markets close on Tuesday, November 4, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the... Read More
SAN FRANCISCO / Aug 05, 2025 / Business Wire / Hinge Health, Inc . (NYSE: HNGE) today announced financial results for the second quarter ended June 30, 2025. "In Q2 we delivered year-over-year revenue growth of 55% and a strong free cash flow margin, underlining the market's embrace of our AI-powered platform," said Daniel Perez, Co-Founder and CEO, Hinge Health. "The journey of automating healthcare delivery will be... Read More
SAN FRANCISCO / Jul 08, 2025 / Business Wire / Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarterly period ended June 30, 2025, after the close of the market on Tuesday, August 5, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the... Read More
Combined with Hinge Health’s AI-powered exercise therapy program, HingeSelect adds access to high-quality in-person providers for members at up to 50% below PPO rates SAN FRANCISCO / Jun 17, 2025 / Business Wire / Hinge Health, Inc. (NYSE:HNGE), today announced the launch of HingeSelect, a high-performance provider network for musculoskeletal (MSK) care. Hinge Health’s technology and in-house orthopedic physicians triage and... Read More
Methodology validated by leading global benefits consultant SAN FRANCISCO / Jun 10, 2025 / Business Wire / Hinge Health, Inc. (NYSE: HNGE) today announced results from a medical claims analysis revealing an average $2,343 savings per member per year on care for chronic musculoskeletal (MSK) conditions and a 2.4x return on investment (ROI) for fully insured health plan members using its digital MSK platform. The methodology... Read More
SAN FRANCISCO / May 21, 2025 / Business Wire / Hinge Health today announced the pricing of its initial public offering of an aggregate 13,666,000 shares of its Class A common stock, 8,522,528 of which are being sold by Hinge Health and 5,143,472 of which are being sold by certain selling stockholders (the “Selling Stockholders”), at a public offering price of $32.00 per share. In addition, the Selling Stockholders have... Read More
C4 Therapeutics